Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP759812.RAjizQNP0YLaB8aep7HWmPwyCKLuJyu6gzh-ySID4mXB8130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP759812.RAjizQNP0YLaB8aep7HWmPwyCKLuJyu6gzh-ySID4mXB8130_assertion type Assertion NP759812.RAjizQNP0YLaB8aep7HWmPwyCKLuJyu6gzh-ySID4mXB8130_head.
- NP759812.RAjizQNP0YLaB8aep7HWmPwyCKLuJyu6gzh-ySID4mXB8130_assertion description "[Heterozygous point mutations at Y641 and A677 in the EZH2 SET domain are prevalent in about 10-24% of Non-Hodgkin lymphomas (NHL).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP759812.RAjizQNP0YLaB8aep7HWmPwyCKLuJyu6gzh-ySID4mXB8130_provenance.
- NP759812.RAjizQNP0YLaB8aep7HWmPwyCKLuJyu6gzh-ySID4mXB8130_assertion evidence source_evidence_literature NP759812.RAjizQNP0YLaB8aep7HWmPwyCKLuJyu6gzh-ySID4mXB8130_provenance.
- NP759812.RAjizQNP0YLaB8aep7HWmPwyCKLuJyu6gzh-ySID4mXB8130_assertion SIO_000772 22850114 NP759812.RAjizQNP0YLaB8aep7HWmPwyCKLuJyu6gzh-ySID4mXB8130_provenance.
- NP759812.RAjizQNP0YLaB8aep7HWmPwyCKLuJyu6gzh-ySID4mXB8130_assertion wasDerivedFrom befree-20140225 NP759812.RAjizQNP0YLaB8aep7HWmPwyCKLuJyu6gzh-ySID4mXB8130_provenance.
- NP759812.RAjizQNP0YLaB8aep7HWmPwyCKLuJyu6gzh-ySID4mXB8130_assertion wasGeneratedBy ECO_0000203 NP759812.RAjizQNP0YLaB8aep7HWmPwyCKLuJyu6gzh-ySID4mXB8130_provenance.